Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease

World Journal of Gastroenterology

Volumn 12, Issue 22, 2006, Pages 3512-3522

  Demetris, A J ^a   Lunz III, John G ^a   Specht, Susan ^a   Nozaki, Isao ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

Biliary wound healing; Ductular reactions; IL 6gp130 signaling

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; STAT3 PROTEIN;

ARTICLE; BILE DUCT; BILE DUCT OBSTRUCTION; CELL CULTURE; CELL METABOLISM; CELL PROLIFERATION; CHRONIC INFLAMMATION; EPITHELIUM CELL; GASTROINTESTINAL TRACT; HEPATOBILIARY SYSTEM; HUMAN; IMMUNE RESPONSE; LIVER CANCER; LIVER CARCINOGENESIS; LIVER DISEASE; MEDICAL RESEARCH; PATHOGENESIS; PATHOPHYSIOLOGY; SCAR FORMATION; SIGNAL TRANSDUCTION; SKIN; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 33745698658     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i22.3512     Document Type: Article

References (148)

1. Lunz JG 3rd, Tsuji H, Nozaki I, Murase N, Demetris AJ. An inhibitor of cyclin-dependent kinase, stress-induced p21Waf-1/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis. Hepatology 2005; 41: 1262-1271
2. Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005; 41: 809-818
3. Demetris AJ, Lunz JG, Subbotin V, Wu T, Nozaki I, Contrucci S, Yin X, Participation of cytokines and growth factors in biliary epithelial proliferation and mito-inhibition during ductular reactions. In, Alpini, G.,et al, Ed. The pathophysiology of biliary epithelia, Georgetown, TX: Landes Bioscie 2003: 167-191
4. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003; 4: 721-732
5. Jacinto A, Martinez-Arias A, Martin P. Mechanisms of epithelial fusion and repair. Nat Cell Biol 2001; 3: E117-123
6. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997; 22: 287-305
7. Redd MJ, Cooper L, Wood W, Stramer B, Martin P. Wound healing and inflammation: embryos reveal the way to perfect repair. Philos Trans R Soc Lond B Biol Sci 2004; 359: 777-784
8. Mammen JM, Matthews JB. Mucosal repair in the gastrointestinal tract. Crit Care Med 2003; 31: S532-537
9. Carlson MA, Longaker MT. The fibroblast-populated collagen matrix as a model of wound healing: a review of the evidence. Wound Repair Regen 2004; 12: 134-147
10. Hinz B, Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb Haemost 2003; 90: 993-1002
11. Nozaki I, Lunz JG 3rd, Specht S, Park JI, Giraud AS, Murase N, Demetris AJ. Regulation and function of trefoil factor family 3 expression in the biliary tree. Am J Pathol 2004; 165: 1907-1920
12. Jacinto A, Martin P. Morphogenesis: unravelling the cell biology of hole closure. Curr Biol 2001; 11: R705-707
13. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112:1776-1784
14. Boyer B, Valles AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 2000; 60:1091-1099
15. Miyazaki H, Van Eyken P, Roskams T, De Vos R, Desmet VJ. Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study. J Hepatol 1993; 19: 353-366
16. Tang L, Tanaka Y, Marumo F, Sato C. Phenotypic change in portal fibroblasts in biliary fibrosis. Liver 1994; 14: 76-82
17. Libbrecht L, Cassiman D, Desmet V, Roskams T. The correlation between portal myofibroblasts and development of intrahepatic bile ducts and arterial branches in human liver. Liver 2002; 22: 252-258
18. Kinnman N, Francoz C, Barbu V, Wendurn D, Rey C, Hultcrantz R, Poupon R, Housset C. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 2003; 83: 163-173
19. Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, Krause R, Lammert F, Langner C, Zatloukal K, Marschall HU, Denk H, Trauner M. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2004; 127: 261-274
20. Ramadori G, Saile B. Portal tract fibrogenesis in the liver. Lab Invest 2004; 84: 153-159
21. Jhandier MN, Kruglov EA, Lavoie EG, Sevigny J, Dranoff JA. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem 2005; 280: 22986-22992
22. Sobesky R, Chollet JM, Prat F, Karkouche B, Pelletier G, Fritsch J. Choury AD, Allonier C, Bedossa P, Buffet C. Inflammatory pseudotumor of the common bile duct. Endoscopy 2003; 35: 698-700
23. Dehner LP, Coffin CM. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin Diagn Pathol 1998; 15: 161-173
24. Inaba K, Suzuki S, Yokoi Y, Ota S, Nakamura T, Konno H, Baba S, Takehara Y, Nakamura S. Hepatic inflammatory pseudotumor mimicking intrahepatic cholangiocarcinoma: report of a case. Surg Today 2003; 33: 714-717
25. Yamamoto K, Phillips MJ. Three-dimensional observation of the intrahepatic lymphatics by scanning electron microscopy of corrosion casts. Anat Rec 1986, 214: 67-70
26. Szabo G, Magyar Z, Szentirmai A, Jakab F, Mihaly K. Bile constituents in blood and lymph during biliary obstruction. II. The absorption and transport of bile acids and bilirubin. Lymphology 1975; 8: 36-42
27. Tsuboi K, Tazuma S, Nishioka T, Chayama K. Partial characterization of cytoprotective mechanisms of lecithin against bile salt-induced bile duct damage. J Gastroenterol 2004; 39: 955-960
28. Barone M, Maiorano E, Ladisa R, Pece A, Berloco P, Strazzabosco M, Caruso ML, Valentini AM, Ierardi E, Di Leo A, Francavilla A. Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats. Virchows Arch 2004; 444: 554-560
29. Patel T, LaRusso NF, Gores GJ. Interleukin-6 suppresses cholangiocyte apoptosis by down-regulation of Bax. Hepatology 1997; 26: 226A
30. Que FG, Gores GJ, LaRusso NF. Development and initial application of an in vitro model of apoptosis in rodent cholangiocytes. Am J Physiol 1997; 272: G106-115
31. Komichi D, Tazuma S, Nishioka T, Hyogo H, Une M, Chayama K. Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes. Dig Dis Sci 2003; 48: 2315-2322
32. Werneburg NW, Yoon JH, Higuchi H, Gores GJ. Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines. Am J Physiol Gastrointest Liver Physiol 2003; 285: G31-36
33. Yoon JH, Higuchi H, Werneburg NW, Kaufmann SH, Gores GJ. Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology 2002; 122: 985-993
34. Lamireau T, Zoltowska M, Levy E, Yousef I, Rosenbaum J, Tuchweber B, Desmouliere A. Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. Life Sci 2003; 72: 1401-1411
35. Kristiansen TZ, Bunkenborg J, Gronborg M, Molina H, Thuluvath PJ, Argani P, Goggins MG, Maitra A, Pandey A. A proteomics analysis of human bile. Mol Cell Proteomics 2004; 3: 715-728
36. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002; 36: 525-531
37. Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, Setchell KD. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatology 1992; 16: 924-930
38. Strain AJ, Crosby HA, Nijjar S, Kelly DA, Hubscher SG. Human liver-derived stem cells. Semin Liver Dis 2003; 23: 373-384
39. Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin Liver Dis 2003; 23: 385-396
40. Saxena. R, Theise N. Canals of Hering: recent insights and current knowledge. Semin Liver Dis 2004; 24:43-48
41. Thorgeirsson SS, Grisham JW. Overview of recent experimental studies on liver stem cells. Semin Liver Dis 2003; 23: 303-312
42. Popper H, Kent G, Stein R. Ductular cell reaction in the liver in hepatic injury. J Mt Sinai Hosp N Y 1957; 24: 551-556
43. Demetris AJ, Sakamoto T, Liu Z, Yokomuro S, Ezure T, Murase Nea, The Ductular Reaction in Liver Disease: emphasis on a type I response, in Normal and Malignant Liver Cell Growth, e. Fleig WE, Editor. Dordecht: Kluwer Academic Publishers 1999: 141-155
44. Lunz JG 3rd, Contrucci S, Ruppert K, Murase N, Fung JJ, Starzi TE, Demetris AJ. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol 2001; 158: 1379-1390
45. Blakolmer K, Seaberg EC, Batts K, Ferrell L, Markin R, Wiesner R, Detre K, Demetris A. Analysis of the reversibility of chronic liver allograft rejection implications for a staging schema. Am J Surg Pathol 1999; 23: 1328-1339
46. Demetris A, Crawford J, Nalesnik M, Randhawa P, Wu T, Minervini M, Transplantation Pathology of the Liver, in Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas, R. Odze, J. Goldblum, and J.M. Crawford, Editors. Philadelphia: WB Saunders 2004: 909-966
47. Wanless I, Physioanatomic Considerations, in Diseases of the Liver, E.R. Schiff, M.F. Sorrell, and W.C. Maddrey, Editors. Philadelphia: Lippincott Williams & Wilkins, 1999: 3-37
48. Demetris AJ. Ischemic cholangitis. Mayo Clin Proc 1992; 67: 601-602
49. Ludwig J, Batts KP, MacCarty RL. Ischemic cholangitis in hepatic allografts. Mayo Clin Proc 1992; 67: 519-426
50. Kukan M, Haddad PS. Role of hepatocytes and bile duct cells in preservation-reperfusion injury of liver grafts. Liver Transpl 2001; 7: 381-400
51. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902
52. Noack K, Bronk SF, Kato A, Gores GJ. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation 1993; 56: 495-500
53. Carrasco L, Sanchez-Bueno F, Sola J, Ruiz JM, Ramirez P, Robles R, Rodriquez JM, Parrilla P. Effects of cold ischemia time on the graft after orthotopic liver transplantation. A bile cytological study. Transplantation 1996; 61: 393-396
54. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651-663
55. Demetris AJ, Fontes P, Lunz J, Specht S, Murase N, Marcos A. Wound healing in the biliary tree of liver allografts. Cell Transplantation (in press) 2006
56. Pirenne J, Gunson B, Khaleef H, Hubscher S, Afford S, McMaster P, Adams D. Influence of ischemia-reperfusion injury on rejection after liver transplantation. Transplant Proc 1997; 29: 366-367
57. Shivakumar P, Campbell KM, Sabla GE, Miethke A, Tiao G, McNeal MM, Ward RL, Bezerra JA. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004; 114: 322-329
58. Geng ZM, Yao YM, Liu QG, Niu XJ, Liu XG. Mechanism of benign biliary stricture: a morphological and immunohistochemical study. World J Gastroenterol 2005; 11: 293-295
59. Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ, Malki S, Alderman BM, Grail D, Hollande F, Heath JK, Ernst M. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002; 8: 1089-1097
60. Lin ZQ Kondo T, Ishida Y, Takayasu T, Mukaida N. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol 2003; 73: 713-721
61. Gallucci RM, Simeonova PP, Matheson JM, Kommineni C, Guriel JL, Sugawara T, Luster MI. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 2000; 14: 2525-2531
62. Muller-Newen G. The cytokine receptor gp130: faithfully promiscuous. Sci STKE 2003; 2003: PE40
63. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003; 149: 1-38
64. Ishihara K, Hirano T. Molecular basis of the cell specificity of cytokine action. Biochim Biophys Acta 2002; 1592: 281-296
65. Inghirami G, Chiarle R, Simmons WJ, Piva R, Schlessinger K, Levy DE. New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell Cycle 2005; 4: 1131-1133
66. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest 1998; 78: 89-100
67. Liu Z, Sakamoto T, Ezure T, Yokomuro S, Murase N, Michalopoulos G, Demetris AJ. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology 1998; 28: 1260-1268
68. Liu Z, Sakamoto T, Yokomuro S, Ezure T, Subbotin V, Murase N, Contrucci S, Demetris AJ. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction. Liver 2000; 20: 114-124
69. Rosen HR, Winkle PJ, Kendall BJ, Diehl DL. Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography. Dig Dis Sci 1997; 42: 1290-1294
70. Scotte M, Daveau M, Hiron M, Delers F, Lemeland JF, Teniere P, Lebreton JP. Interleukin-6 (IL-6) and acute-phase proteins in rats with biliary sepsis. Eur Cytokine Netw 1991; 2: 177-182
71. Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000; 46: 725-731
72. Akiyama T, Hasegawa T, Sejima T, Sahara H, Seto K, Saito H, Takashima S. Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage. Hepatogastroenterology 1998; 45: 665-671
73. Nozaki I, Lunz JG 3rd, Specht S, Stolz DB, Taguchi K, Subbotin VM, Murase N, Demetris AJ. Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest 2005; 85: 109-123
74. Ezure T, Sakamoto T, Tsuji H, Lunz JG 3rd, Murase N, Fung JJ, Demetris AJ. The development and compensation of biliary cirrhosis in interleukin-6- deficient mice. Am J Pathol 2000; 156: 1627-1639
75. Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander WS, Wicks IP, Tarlinton DM, Novak U, Heath JK, Dunn AR. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001; 194: 189-203
76. Kanai M, Mullen C, Podolsky DK. Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells. Proc Natl Acad Sci USA 1998; 95: 178-182
77. Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996; 274: 262-265
78. Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, DeBeaumont M, Sands BE, Mahida YR. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993; 268: 6694-6702
79. Nozaki I, Lunz JG 3rd, Specht S, Stolz DB, Taguchi K, Subbotin VM, Murase N, Demetris AJ. Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest 2005; 83: 109-123
80. Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro, Hepatology 1994; 20: 376-382
81. Yokomuro S, Lunz JG 3rd, Sakamoto T, Ezure T, Murase N, Demetris AJ. The effect of interieukin-6 (IL-6)/gp130 signalling on biliary epithelial cell growth, in vitro. Cytokine 2000; 12: 727-730
82. Yokomuro S, Tsuji H, Lunz JG 3rd, Sakamoto T, Ezure T, Murase N, Demetris AJ. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 2000; 32: 26-35
83. Tomasetto C, Masson R, Linares JL, Wendling C, Lefebvre O, Chenard MP, Rio MC. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 2000; 118: 70-80
84. Gum JR Jr, Hicks JW, Gillespie AM, Carlson EJ, Komuves L, Kamik S, Hong JC, Epstein CJ, Kim YS. Goblet cell-specific expression mediated by the MUC2 mucin gene promoter in the intestine of transgenic mice. Am J Physiol 1999; 276: G666-676
85. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotem. Gastroenterology 1995; 109: 516-523
86. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 1994; 94: 376-383
87. Tomasetto C, Rio MC, Gautier C, Wolf C, Hareuveni M, Chambon P, Lathe R. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 1990; 9: 407-414
88. Rio MC, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, Chenard MP, Batzenschlager A, Chambon P. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988; 241: 705-708
89. Hertel SC, Chwieralski CE, Hinz M, Rio MC, Tomasetto C, Hoffmann W. Profiling trefoil factor family (TFF) expression in the mouse: identification of an antisense TFFl-related transcript in the kidney and liver. Peptides 2004; 25: 755-7562
90. Sasaki M, Tsuneyama K, Saito T, Kataoka H, Mollenhauer L Poustka A, Nakanuma Y. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology. Liver Int 2004; 24: 29-37
91. Sasaki M, Tsuneyama K, Nakanuma Y. Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolitiasis and cholangiocarcinoma. Lab Invest 2003; 83: 1403-1413
92. Srivatsa G, Giraud AS, Ulaganathan M, Yeomans ND, Dow C, Nicoll AJ. Biliary epithelial trefoil peptide expression is increased in biliary diseases. Histopathology 2002; 40: 261-268
93. Kimura Y, Leung PS, Kenny TP, Van De Water J, Nishioka M, Giraud AS, Neuberger J, Benson G, Kaul R, Ansari AA, Coppel RL, Gershwin ME. Differential expression of intestinal trefoil factor in biliary epithelia] cells of primary biliary cirrhosis. Hepatology 2002; 36: 1227-1235
94. Marenholz I, Zirra M, Fischer DF, Backendorf C, Ziegler A, Mischke D. Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library. Genome Res 2001; 11: 341-355
95. Cabral A, Voskamp P, Cleton-Jansen AM, South A, Nizefic D, Backendorf C. Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function. J Biol Chem 2001; 276: 19231-19237
96. Patel S, Kartasova T, Segre JA. Mouse Sprr locus: a tandem array of coordinately regulated genes. Mamm Genome 2003; 14: 140-148
97. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21. J Invest Dermatol 1996; 106: 989-992
98. Elder JT, Zhao X. Evidence for local control of gene expression in the epidermal differentiation complex. Exp Dermatol 2002; 11:406-412
99. Tarcsa E, Candi E, Kartasova T, Idler WW, Marekov LN, Steinert PM. Structural and transglutarninase substrate properties of the small proline-rich 2 family of cornified cell envelope proteins. J Biol Chem 1998; 273: 23297-23303
100. Stern LE, Erwin CR, Falcone RA, Huang FS, Kemp CJ, Williams JL, Warner BW. cDNA microarray analysis of adapting bowel after intestinal resection. J Pediatr Surg 2001; 36: 190-195
101. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881-884
102. Mueller A, O'Rourke J, Grimm J, Guillemin K, Dixon MF, Lee A, Falkow S. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci USA 2003; 100: 1292-1297
103. Knight PA, Pemberton AD, Robertson KA, Roy DJ, Wright SH, Miller HR. Expression profiling reveals novel innate and inflammatory responses in the jejunal epithelial compartment during infection with Trichinella spiralis. Infect Immun 2004; 72: 6076-6086
104. Hong SH, Nah HY, Lee JY, Lee YJ, Lee JW, Gye MC, Kim CH, Kang BM, Kim MK. Estrogen regulates the expression of the small proline-rich 2 gene family in the mouse uterus. Mol Cells 2004; 17: 477-484
105. Tan YF, Li FX, Piao YS, Sun XY, Wang YL. Global gene profiling analysis of mouse uterus during the oestrous cycle. Reproduction 2003; 126: 171-182
106. Song HJ, Poy G, Darwiche N, Lichti U, Kuroki T, Steinert PM, Kartasova T. Mouse Sprr2 genes: a clustered family of genes showing differential expression in epithelial tissues. Genomics 1999; 55: 28-42
107. Zimmermann N, Doepker MP, Witte DP, Stringer KF, Fulkerson PC, Pope SM, Brandt EB, Mishra A, King NE, Nikolaidis NM, Wills-Karp M, Finkelman FD, Rothenberg ME. Expression and regulation of small proline-rich protein 2 in allergic inflammation. Am J Respir Cell Mol Biol 2005; 32: 428-435
108. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60-66
109. Clouston AD, Powell EE. Interaction of non-alcoholic fatty liver disease with other liver diseases. Best Pract Res Clin Gastroenterol 2002; 16: 767-781
110. Demetris AJ, Sakamoto T, Liu Z, Yokomuro S, Ezure T, Murase N, Blakolmer K, The Ductular Reaction in Liver Disease emphasis on a type I response, in Normal and Malignant Liver Cell Growth, W.E. Fleig, Editor. Dordecht: Kluwer Academic Publishers 1999: 141-155
111. Sirica AE, Mathis GA, Sano N, Elmore LW. Isolation, culture, and transplantation of intrahepatic biliary epithelial cells and oval cells. Pathobiology 1990; 58: 44-64
112. Zhang M, Thorgeirsson SS. Modulation of connexins during differentiation of oval cells into hepatocytes. Exp Cell Res 1994; 213: 37-42
113. Martin KR, Barrett JC. Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity. Hum Exp Toxicol 2002; 21: 71-75
114. Marshall A, Rushbrook S, Davies SE, Morris LS, Scott IS, Vowler SL, Coleman N, Alexander G. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 2005; 128: 3342
115. Kobayashi S, Matsushita K, Saigo K, Urashima T, Asano T, Hayashi H, Ochiai T. P21WAF1/CIP1 messenger RNA expression in hepatitis B, C virus-infected human hepatocellular carcinoma tissues. Cancer 2001; 91: 2096-2103
116. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p2l up-regulation accompany impaired regeneration of fatty livers. Am J Pathol 2002; 161: 155-161
117. Sawada N, Kojima T, Obata H, Isomura H, Atsumi S, Sawaki M, Tsuzuki N, Tobioka H, Kokai Y, Satoh M, Mori M. Expression of p2l(waf-1/cip-1) is significantly induced in the livers of LEC rats with chronic liver injury. Jpn J Cancer Res 1996; 87: 1102-1105
118. Koteish A, Yang S, Lin H, Huang J, Diehl AM. Ethanol induces redox-sensitive cell-cycle inhibitors and inhibits liver regeneration after partial hepatectomy. Alcohol Clin Exp Res 2002; 26: 1710-1708
119. Blakolmer K, Jain A, Ruppert K, Gray E, Duquesnoy R, Murase N, Starzl TE, Fung JJ, Demetris AJ. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation 2000; 69: 2330-2336
120. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, Fung J, Gouw A, Gustafsson B, Haga H, Harrison D, Hart J, Hubscher S, Jaffe R, Khettry U, Lassman C, Lewin K, Martinez O, Nakazawa Y, Neil D, Pappo O, Parizhskaya M, Randhawa P, Rasoul-Rockenschaub S, Reinholt F, Reynes M, Robert M, Tsamandas A, Wanless I, Wiesner R, Wernerson A, Wrba F, Wyatt J, Yamabe H. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000; 31: 792-799
121. Oguma S, Belle S, Starzl TE, Demetris AJ. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology 1989; 9: 204-209
122. Omori N, Evarts RP, Omori M, Hu Z, Marsden ER, Thorgeirsson SS. Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat. Lab Invest 1996; 75: 15-24
123. Sakamoto T, Ezure T, Lunz J, Murase N, Tsuji H, Fung JJ, Demetris AJ. Concanavalin A simultaneously primes liver hematopoietic and epithelial progenitor cells for parallel expansion during liver regeneration after partial hepatectomy in mice. Hepatology 2000; 32: 256-267
124. Chan KS, Sano S, Kiguchi K, Anders J, Komazawa N, Takeda J, DiGiovanni J. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 2004; 114: 720-728
125. Campisi J. Cancer and ageing: rival demons? Nat Rev Cancer 2003; 3: 339-349
126. Haura EB, Turkson J, Jove R. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2005; 2: 315-324
127. Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005; 41: 2502-2512
128. Koike N, Saitoh K, Todoroki T, Kawamoto T, Iwasaki Y, Nakamura K. Cell proliferation kinetics of the bile duct epithelium of the rat. Cell Proli 1993; 26: 183-193
129. Nakanuma Y, Kono N. Expression of vimentin in proliferating and damaged bile ductules and interlobular bile ducts in nonneoplastic hepatobiliary diseases. Mod Pathol 1992; 5: 550-554
130. Milani S, Herbst H, Schuppan D, Nieclobitek G, Kim KY, Stein H. Vimentin expression of newly formed rat bile duct epithelial cells in secondary biliary fibrosis. Virchows Arch A Pathol Anat Histopathol 1989; 415: 237-242
131. Haruna Y, Saito K, Spaulding S, Nalesnik MA, Gerber MA. Identification of bipotential progenitor cells in human liver development. Hepatology 1996; 23: 476-481
132. Terada T, Ashida K, Kitamura Y, Matsunaga Y, Takashima K, Kato M, Ohta T. Expression of epithelial-cadherin, alpha-catenin and beta-catenin during human intrahepatic bile duct development: a possible role in bile duct morphogenesis. J Hepatol 1998; 28: 263-269
133. Camargo CA Jr, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 1513-1520
134. Gao B. Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure. Alcohol 2004; 34: 59-65
135. Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 2004; 40: 933-941
136. Selzner M, Graf R, Clavien PA. IL-6: a magic potion for liver transplantation? Gastroenterology 2003; 1Z5: 256-259
137. Sun Z, Klein AS, Radaeva S, Hong F, El-Assal O, Pan HN, Jaruga B, Batkai S, Hoshino S, Tian Z, Kunos G, Diehl AM, Gao B. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 2003; 125: 202-215
138. Kimizuka K, Nakao A, Nalesnik MA, Demetris AJ, Uchiyama T, Ruppert K, Fink MP, Stolz DB, Murase N. Exogenous IL-6 inhibits acute inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation. Am J Transplant 2004; 4: 482-494
139. Safadi R, Friedman SL. Hepatic fibrosis - role of hepatic stellate cell activation. MedGenMed 2002; 4: 27
140. Tillmann HL, Manns MP, Rudolph KL. Merging models of hepatitis C virus pathogenesis. Semin Liver Dis 2005; 25: 84-92
141. Watanabe S, Matsuda A, Suzuki Y, Kondo K, Ikeda Y, Hashimoto H, Umemura K. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors. Br J Pharmacol 2000; 130: 307-314
142. Ikeda H, Inao M, Fujiwara K. Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells. Biochem Biophys Res Commun 1996; 227: 322-327
143. Naftalin R. Alterations in colonic barrier function caused by a low sodium diet or ionizing radiation. J Environ Pathol Toxicol Oncol 2004; 23: 79-97
144. Wengrower D, Zannineli G, Pappo O, Latella G, Sestieri M, Villanova A, Faitelson Y, Pines M, Goldin E. Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1. Inflamm Bowel Dis 2004; 10: 536-545
145. Ramos SG, Montenegro AP, Goissis G, Rossi MA. Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis. Pathol Int 1994; 44: 655-661
146. Yuan GJ, Zhang ML, Gong ZJ. Effects of PPARg agonist pioglitazone on rat hepatic fibrosis. World J Gastroenterol 2004; 10: 1047-1051
147. Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Biochem Biophys Res Commun 2004; 315: 187-195
148. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF, Jr., Motomura K, Anania FA, Willson TM, Tsukamoto H. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem 2000; 275: 35715-35822